Inertia Enterprises burst onto the scene in February with a $450 million Series A, making it one of the best capitalized startups in the industry, aiming to bring laser-based fusion reactors to market.
Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.
Modern scientific societies are increasingly vulnerable due to their dependence on membership fees and journal subscriptions, which are being challenged by the rise of virtual networking and open-access publishing.
Ushering in the Golden Age of Innovation is about more than just winning the global tech race - it's about securing the safety and prosperity of our country for generations to come. Our bill is an important step in this effort and will better ensure the United States has the infrastructure in place to lead the 21st century.
Librarians have been actively collaborating and talking about it almost every day, whether it's creating tutorials and digital learning objectives or thinking about the conversations to have with instructors. It can feel like cognitive dissonance to be actively working with AI on a regular basis and also saying we're constantly thinking about the harms and the biases.
We don't know what exactly investigators found or whether they are in any way harmful. However, we do have an intriguing clue. The property was linked to Jia Bei Zhu, a 62-year-old Chinese citizen who was arrested in October 2023 on charges of manufacturing and distributing misbranded medical devices and making false statements to the FDA, according to NBC News.
Many researchers are surprised and relieved over an unusual step taken by the US National Institutes of Health (NIH): the agency is rolling back the red tape on a host of basic-science experiments that involved human participants and had been classified as clinical trials. The decision, which was announced on 29 January and is part of a broader NIH effort to reduce administrative burden, should free such research from the heavy bureaucratic requirements that are designed for clinical trials but are sometimes ill-suited to other fields, such as basic psychology and behavioural studies.
Now, researchers have created an artificial-intelligence system that vastly simplifies and accelerates the process of chemical synthesis. The system, which is called MOSAIC and is described in a study published in Nature on 19 January, recommended conditions that researchers were able to use to generate 35 compounds with the potential to become products like pharmaceuticals, agrochemicals or cosmetics without needing to do any further trawling or tweaking.
For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of HIV. Each of these patients has experienced long-term viral control - in some cases for over a decade - without antiretroviral therapy (ART), as AIDSMap notes, though some doctors describe them as being in "remission." While the patients have shown no signs of HIV since stopping ART, at least some uncertainty remains as to whether the virus could eventually rebound in them.
Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies on dogs should be slashed by 2030. The long-term vision is 'a world where the use of animals in science is eliminated in all but exceptional circumstances'.
In fact, Stawicki was on a mission to save the lives of around 1,000 zebrafish ( Danio rerio) in her laboratory. Similarities between lines of hair cells on the fish's flanks and those in the mammalian inner ear enable her to use them as a model to study hearing problems in humans caused by some antibiotics and chemotherapy drugs. A sensor had picked up that the lab's heating system had been knocked out by a power fault.
Calling nanoscientists: your field needs you to try to replicate a landmark finding that quantum dots can act as biosensors inside living cells. As part of the first large-scale effort in the physical sciences to tackle the reproducibility crisis, researchers in France and the Netherlands are offering funds and resources in exchange for a few months of work. "We are trying to use
Some clinicians have an uncanny quality. A colleague describes herself and others with this instinct as "witchy"-a capacity to know things about patients they haven't said yet, to follow a stray association to a song lyric or a half-remembered cultural reference and arrive, reliably, at something the patient urgently needed to say but couldn't reach on their own. We see with artificial intelligence these intriguing possibilities for discovery, especially as connections that human beings never would see pop out of apparently unrelated data.
Countless millions of nonhuman animals (animals) of all sorts are used in a diverse array of laboratory research. Their treatment varies from being unspeakably inhumanely abused to being treated with kindness, depending on the questions at hand and the values and attitudes of the researchers themselves. The lives of these animals truly are hidden, and most people are incredulous when they learn that laboratory rats and mice still are not considered "animals" under the current federal Animal Welfare Act.
Martschenko's argument is largely that genetic research and data have almost always been used thus far as a justification to further entrench extant social inequalities. But we know the solutions to many of the injustices in our world-trying to lift people out of poverty, for example-and we certainly don't need more genetic research to implement them. Trejo's point is largely that more information is generally better than less.
Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging. At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
I'm less interested in topics than in questions, and I'm less interested in publishing than I am in curation. When I've testified before Congress or dealt with an appropriations bill or a budget negotiation, this question, of what is the return on investments when you're doing R&D, comes up quite often. It's been asked by economists in very formal ways since at least the 1950s, but the data and the methods that were available were really not very strong.
